Harmony Biosciences Holdings (HRMY) Amortizatization of Intangibles (2019 - 2026)
Harmony Biosciences Holdings' (HRMY) quarterly Amortizatization of Intangibles came in at $220000.0 in Q1 2026, down 96.31% year-on-year from $6.0 million in Q1 2025, and down 21.71% quarter-over-quarter from $281000.0 in Q4 2025.
Harmony Biosciences Holdings (HRMY) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings has disclosed Amortizatization of Intangibles across 8 years of filings, most recently posting $220000.0 for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $220000.0, down 96.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.4 million (down 68.91% YoY), and the FY2025 annual result was $1.5 million, down 93.62% from the prior year.
- Amortizatization of Intangibles came in at $220000.0 for Q1 2026 at Harmony Biosciences Holdings, down from $281000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $22.1 million in Q4 2024 to a low of -$15.2 million in Q4 2023.
- The 5-year median for Amortizatization of Intangibles is $6.0 million (2022), against an average of $4.6 million.
- Across the five-year window, Amortizatization of Intangibles jumped 1825.0% in 2022 and sank 354.47% in 2023, its largest moves.
- Harmony Biosciences Holdings' Amortizatization of Intangibles stood at $6.0 million in 2022, then tumbled by 354.47% to -$15.2 million in 2023, then surged by 245.53% to $22.1 million in 2024, then sank by 98.73% to $281000.0 in 2025, then slipped by 21.71% to $220000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $220000.0 (Q1 2026), $281000.0 (Q4 2025), and $6.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Harmony Biosciences Holdings | 1.92 Bn | 1.28 Bn | 170.88 Mn | 220,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 220,000.00 |
| Mar 31, 2026 | 220,000.00 |
| Dec 31, 2025 | 281,000.00 |
| Dec 31, 2025 | 281,000.00 |
| Sep 30, 2025 | 5.96 Mn |
| Sep 30, 2025 | 5.96 Mn |
| Jun 30, 2025 | 5.96 Mn |
| Jun 30, 2025 | 5.96 Mn |
| Mar 31, 2025 | 5.96 Mn |
| Mar 31, 2025 | 5.96 Mn |
| Dec 31, 2024 | 22.08 Mn |
| Dec 31, 2024 | 22.08 Mn |
| Sep 30, 2024 | 5.96 Mn |
| Sep 30, 2024 | 5.96 Mn |
| Jun 30, 2024 | 5.96 Mn |
| Jun 30, 2024 | 5.96 Mn |
| Mar 31, 2024 | 5.96 Mn |
| Mar 31, 2024 | 5.96 Mn |
| Dec 31, 2023 | -15.17 Mn |
| Dec 31, 2023 | -15.17 Mn |